Novo Nordisk's CagriSema Falls Short in Head to Head Trial vs Zepbound Bryce Platt, PharmD posted on the topic LinkedIn Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide C194H312N54O59S2 CID 171397054 PubChem Cagrilintide 5mg + Tirzepatide 10mg Injection (15mg)